Carta al Director
Tratamiento de una crisis hipertensiva con clevidipino en una en paciente crítica no respondedora a dosis altas de nitroglicerina, labetalol, urapidilo, doxazosina y furosemida
Management of hypertensive crisis with clevidipine in the perioperative setting of a critically ill patient, non-responder to high doses of nitroglycerin, labelatol, urapidil, doxazosin and furosemide
Leído
355
Vecesse ha leído el artículo
123
Total PDF
232
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 3 | 3 | 6 |
| 2025 4 | 1 | 0 | 1 |
| 2025 3 | 1 | 1 | 2 |
| 2024 12 | 1 | 3 | 4 |
| 2024 11 | 1 | 2 | 3 |
| 2024 9 | 3 | 2 | 5 |
| 2024 4 | 4 | 4 | 8 |
| 2024 3 | 1 | 0 | 1 |
| 2024 1 | 1 | 0 | 1 |
| 2023 11 | 1 | 2 | 3 |
| 2023 10 | 3 | 5 | 8 |
| 2023 9 | 2 | 2 | 4 |
| 2023 6 | 2 | 1 | 3 |
| 2023 2 | 3 | 2 | 5 |
| 2022 11 | 1 | 0 | 1 |
| 2022 9 | 2 | 2 | 4 |
| 2022 7 | 1 | 2 | 3 |
| 2022 6 | 1 | 0 | 1 |
| 2022 3 | 1 | 0 | 1 |
| 2022 2 | 2 | 2 | 4 |
| 2021 1 | 3 | 1 | 4 |
| 2021 12 | 4 | 0 | 4 |
| 2021 11 | 3 | 2 | 5 |
| 2021 10 | 2 | 4 | 6 |
| 2021 9 | 5 | 4 | 9 |
| 2021 8 | 4 | 6 | 10 |
| 2021 7 | 3 | 2 | 5 |
| 2021 6 | 8 | 7 | 15 |
| 2021 5 | 14 | 10 | 24 |
| 2021 4 | 107 | 35 | 142 |
| 2021 3 | 44 | 11 | 55 |
| 2021 2 | 0 | 3 | 3 |
| 2020 12 | 0 | 1 | 1 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 0 | 2 | 2 |
Mostrar todo
